Medical News

RSS

Adeona expands and enhances zinc-based product candidate portfolio

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it has acquired access to clinical data supporting a zinc-based therapy for the prevention of infections in the elderly. This acquisition expands and enhances Adeona's zinc-based product candidate portfolio that already includes its proprietary zinc-based tablets for use in the dietary management of mild to moderate Alzheimer's disease and mild cognitive impairment patients, and age-related macular degeneration.

16 Dec 2010

Centene anticipates premium and service revenue in the range of $4.9 billion to $5.1 billion for fiscal 2011

Centene Corporation announced today its 2011 financial guidance. The discussions below are in the context of continuing operations and all financial ratios exclude premium taxes.

16 Dec 2010

WHO report shows significant progress in global malaria fight, highlights need for continued funding

Since 2008, global malaria control efforts have "helped reduce infections across Africa and [eliminate] the disease in Morocco and Turkmenistan, but a slowdown in funding risks undoing those achievements," according to the WHO's annual malaria report, which was released on Tuesday, Reuters reports (Nebehay, 12/14).

16 Dec 2010

Miracor granted CE-Mark for PICSO Impulse System to improve ACS revascularization following PCI

Miracor Medical Systems GmbH announced today that the company has received CE-mark for the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI).

16 Dec 2010

New York Times examines debate over aid strategy in Afghanistan

"At least 100 relief workers in Afghanistan have been killed so far this year, far more than in any previous year, prompting a debate within humanitarian organizations about whether American military strategy is putting them and the Afghans they serve at unnecessary risk. ... Has American counterinsurgency strategy militarized the delivery of aid?" the New York Times writes looking at the different perspectives in this debate.

16 Dec 2010

Living near freeway linked to increased risk of autism

Living near a freeway may be associated with increased risk of autism, according to a study published by a team of researchers from Children's Hospital Los Angeles, the Keck School of Medicine of the University of Southern California (USC) and the UC Davis MIND Institute.

16 Dec 2010

SIDS deaths surge 33% on New Year's Day

Not a happy holiday thought, but an important one: The number of babies who die of SIDS, or sudden infant death syndrome, surges by 33 percent on New Year's Day. The suspected reason? Alcohol consumption by caretakers the night before.

16 Dec 2010

International Bionic Engineering Conference to be held from 18-20 September, 2011

The International Bionic Engineering Conference 2011 organised by Elsevier, the leading publisher of scientific, technical and medical information products and services, aims to bridge the gap between academic research and industrial development in a field that is rapidly growing and gaining recognition across many disciplines.

16 Dec 2010

Cord Blood America announces acquisition of Cryo-Cell Mexico to gain profit

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced in a comprehensive interview with analyst Francis Gaskins that the acquisition of Cyro-Cell Mexico would give CBAI a "clear path to profitability."

16 Dec 2010

Oxygen Biotherapeutics and SMP sign Binding Letter of Intent for joint chronic ischemic wound research

Oxygen Biotherapeutics, Inc. and privately held Sarasota Medical Products, Inc. (SMP) of Sarasota, FL, today announced they signed a Binding Letter of Intent to determine the feasibility of pursuing a joint research and development venture for treating chronic ischemic wounds. The venture will be based on combining Oxygen's Wundecyte™ PFC formulation with SMP's topical medical devices.

16 Dec 2010

Affordable Care Act provisions will increase breastfeeding among working mothers

Millions of working mothers were not able to express breast milk while at work until the Affordable Care Act of 2010 (ACA). The law requires employers to provide nursing breaks and a private, sanitary place to express breast milk for most mothers employed on an hourly basis. The ACA provisions for breastfeeding cover three-fifths of employed women living in families below 350 percent of the government poverty line (about $50,000 for a family of two).

16 Dec 2010

Precision BioSciences receive $3 million to develop DNE technology

Precision BioSciences, today announced that it has been awarded over $3 million across four government grants. These grants were each awarded to Precision during the 4th Quarter of 2010 and came from the National Institute of Standards and Technology, the Treasury Department, the National Institute of Health, and the State of North Carolina.

16 Dec 2010

Boehringer Ingelheim's selection of development candidate triggers € 6.5 million milestone payment to Orexo

Orexo AB and Boehringer Ingelheim announced today that Boehringer Ingelheim has selected a development candidate resulting from the worldwide exclusive research, development and commercialisation agreement which Boehringer Ingelheim had signed in November 2005 with Biolipox, a Swedish research-based pharmaceutical company acquired by Orexo in October 2007.

16 Dec 2010

NextGen Healthcare announces partnership with Wills Eye for meaningful use

NextGen Healthcare Information Systems, a wholly owned subsidiary of Quality Systems, and leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Wills Eye Health System to deploy NextGen® Ambulatory EHR and NextGen® Practice Management.

16 Dec 2010

Study finds that immobilization devices significantly reduce braking response time

Patients recovering from a right foot injury or surgery should think twice about how soon they want to begin driving again. According to a new study from the Journal of Bone and Joint Surgery (JBJS), it takes much longer to brake when the driver is wearing an immobilization device - like a splint or brace, than it does when wearing normal footwear.

16 Dec 2010

MDA commits to invest funds in FSMA Quinazoline Program

The MDA has committed to invest funds in the FSMA Quinazoline Program at Repligen Corporation to assist in advancing the program to an IND filing with the FDA.

16 Dec 2010

Alzheimer's Foundation of America praises House, Senate passage of National Alzheimer's Project Act

The Alzheimer's Foundation of America issued this statement today regarding passage of the National Alzheimer's Project Act. The National Alzheimer's Project Act would create the National Alzheimer's Project, which would coordinate government efforts to prevent and treat the disease and create a national strategy for defeating Alzheimer's disease.

16 Dec 2010

Scientists demonstrate similarity between individual development and phylogeny in level of gene expression

Similarities in the embryonic development of various animal species are also found at molecular level. The astonishing similarity in the appearance of embryos from different animal species was observed as far back as the 19th century by scientists such as Karl von Baer, Charles Darwin and Ernst Haeckel.

16 Dec 2010

Justice Department will appeal health ruling, Virginia decision viewed as one step in long path to Supreme Court

The Justice Department makes clear its intent to appeal the Virginia federal court decision striking at the health overhaul's individual mandate. Meanwhile, news outlets explore the reach of that decision, noting that it may be more narrow than the reaction immediately following its release would indicate. Also explored: the next steps for this central provision within the health law and how it has become the sweeping overhaul's "central villain."

16 Dec 2010

Study describes CC3/TIP30 protein regulate metabolic adaptation of tumor cells to glucose limitation

Bionovo, today announced the publication of a study entitled "CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation" in the journal Cell Cycle.

16 Dec 2010

Medical News

Adeona expands and enhances zinc-based product candidate portfolio

Centene anticipates premium and service revenue in the range of $4.9 billion to $5.1 billion for fiscal 2011

WHO report shows significant progress in global malaria fight, highlights need for continued funding

Miracor granted CE-Mark for PICSO Impulse System to improve ACS revascularization following PCI

New York Times examines debate over aid strategy in Afghanistan

Living near freeway linked to increased risk of autism

SIDS deaths surge 33% on New Year's Day

International Bionic Engineering Conference to be held from 18-20 September, 2011

Cord Blood America announces acquisition of Cryo-Cell Mexico to gain profit

Oxygen Biotherapeutics and SMP sign Binding Letter of Intent for joint chronic ischemic wound research

Affordable Care Act provisions will increase breastfeeding among working mothers

Precision BioSciences receive $3 million to develop DNE technology

Boehringer Ingelheim's selection of development candidate triggers € 6.5 million milestone payment to Orexo

NextGen Healthcare announces partnership with Wills Eye for meaningful use

Study finds that immobilization devices significantly reduce braking response time

MDA commits to invest funds in FSMA Quinazoline Program

Alzheimer's Foundation of America praises House, Senate passage of National Alzheimer's Project Act

Scientists demonstrate similarity between individual development and phylogeny in level of gene expression

Justice Department will appeal health ruling, Virginia decision viewed as one step in long path to Supreme Court

Study describes CC3/TIP30 protein regulate metabolic adaptation of tumor cells to glucose limitation

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News